Literature DB >> 29710480

MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.

Xin-Ping Wang1, Jing Yao1, Jiao Guan1, Zun-Qiang Zhou1, Zheng-Yun Zhang1, Jun Yang2.   

Abstract

MicroRNA-542-3p (miR-542-3p) functions as a tumor suppressor in many human cancers, but its biological roles in hepatocellular carcinoma (HCC) remains to be further explored. In our study, we revealed that miR-542-3p was frequently down-expressed in HCC cell lines and tissues using real-time quantitative reverse-transcription PCR (qRT-PCR). Overexpression of miR-542-3p inhibits the proliferation of HCC cells via induction of apoptosis and cell cycle arrest. Furthermore, we confirmed that survivin was a direct target of miR-542-3p in HCC cells, and overexpression of survivin attenuated the miR-542-3p-induced inhibition of HCC cell proliferation. A negative association between miR-542-3p and survivin mRNA levels was also found in HCC tissues. These findings showed that miR-542-3p inhibits the proliferation of HCC cells by targeting survivin, indicating that miR-542-3p/survivin signaling axis might serve as a potential therapeutic target in the treatment of HCC.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Hepatocellular carcinoma; Survivin; Tumor growth; microRNA-542-3p

Mesh:

Substances:

Year:  2018        PMID: 29710480     DOI: 10.1016/j.biopha.2018.01.131

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.

Authors:  Nuobei Zhang; Xin Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-05       Impact factor: 6.730

2.  A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer.

Authors:  Hossein Hozhabri; Marziyeh Mazaheri Moghaddam; Madiheh Mazaheri Moghaddam; Ali Mohammadian
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

3.  Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.

Authors:  Chunmei Zhang; Yang Li; Wancheng Zhao; Guipeng Liu; Qing Yang
Journal:  Cancer Med       Date:  2020-03-13       Impact factor: 4.452

Review 4.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

5.  Long non‑coding RNA NR2F1‑AS1 facilitates the osteosarcoma cell malignant phenotype via the miR‑485‑5p/miR‑218‑5p/BIRC5 axis.

Authors:  Guanghui Jia; Yalei Wang; Yali Yu; Zijun Li; Xiangyu Wang
Journal:  Oncol Rep       Date:  2020-07-20       Impact factor: 3.906

6.  SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle.

Authors:  Gang Dong; Shanshan Zhang; Shen Shen; Lulu Sun; Xuemei Wang; Haiyu Wang; Jie Wu; Tingting Liu; Chaoyan Wang; Huanbin Wang; Taiying Lu; Benchen Rao; Zhigang Ren
Journal:  Cell Death Dis       Date:  2020-10-09       Impact factor: 8.469

7.  miR-542-3p Attenuates Bone Loss and Marrow Adiposity Following Methotrexate Treatment by Targeting sFRP-1 and Smurf2.

Authors:  Ya-Li Zhang; Liang Liu; Yu-Wen Su; Cory J Xian
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

8.  Granule of BU-XIN RUAN-MAI Attenuates the Patients' Angina Pectoris of Coronary Heart Disease via Regulating miR-542-3p/GABARAP Signaling.

Authors:  Dong Yan; Li-Li Zhao; Bo-Wen Yue; Hui Qian; Zi-Han Zhang; Ning Wang; Shi-Hai Yan; Yu-Liang Qian
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-26       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.